Furthermore, its intracerebroventricular injection prevents sleep loss-induced memory impairment in APP/PS1 mice (Tabassum et al., 2019) and ameliorates cognitive impairment in Aβ42-injected mice by reducing the level of Aβ42 (Liu et al., 2014). This evidence concerns the gene APP and memory impairment.